Michael Farah

Board Member

Michael Farah has been involved in principal investing and investment banking since 2001. Prior to Linden, he was a Vice President at Metalmark Capital where he focused on healthcare investing. Mr. Farah began his career at UBS Investment Bank where he focused on M&A advisory and capital raising transactions for the healthcare sector and also spent three years with Summit Partners as a private equity associate.

Mr. Farah holds a Bachelor of Arts in Finance, with honors, from Carnegie Mellon University and an MBA from Harvard Business School.

Company Blog

May 30, 2019
FDA’s Top 483 Observations for 2018: A Reflection of Industry’s…
Understanding industry’s compliance direction, and how this data can help evaluate the capability and… Read More
May 9, 2019
Meet the Expert: Marc Klinkhamer
Meet Marc Klinkhamer, a Principal Consultant and medical device expert based out of ProPharma… Read More
April 11, 2019
Utilizing an Agile Framework When Implementing ATMPs
Agile methodology presents a solution for organizations needing to address the timeline constraints of… Read More
More Articles

UPCOMING Events

June 28, 2019
Dutch Biotech Event 2019 – HollandBIO
Whether you’re working at a biotech startup, scale-up, runner-up or an established multinational, you do not... Read More
July 25, 2019
ISPE San Francisco 25th Annual Fun Day
Our team looks forward to this event each year, and we can’t wait to celebrate the 25th anniversary with... Read More
September 09, 2019
Cell & Gene Therapy Conference
Meet ProPharma Group at the Cell and Gene Therapy Conference for Bioprocessing and Commercialization, part of ... Read More
All Events
Contact Us